The role of extracellular signal-regulated protein kinase in transcriptional regulation of the hypoxia marker carbonic anhydrase IX

Journal of Cellular Biochemistry

Volumn 97, Issue 1, 2006, Pages 207-216

  Kaluz, Stefan ^a,b   Kaluzová, Milota ^a   Stanbridge, Eric J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Carbonic anhydrase IX; Cell density; Extracellular signal regulated protein kinase; Hypoxia

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; BINDING PROTEIN; CARBONATE DEHYDRATASE IX; HYPOXIA INDUCIBLE FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1 INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2 INHIBITOR; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN P300; PROTEIN PR1; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL DENSITY; CELL STRAIN MCF 7; CULTURE MEDIUM; DNA RESPONSIVE ELEMENT; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBROSARCOMA; HELA CELL; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

CARBONIC ANHYDRASES; CELL LINE, TUMOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HUMANS; TRANSCRIPTION, GENETIC;

MINK CELL FOCUS-FORMING VIRUS;

EID: 30044437912     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20633     Document Type: Article

References (30)

1. Conrad PW, Freeman TL, Beitner-Johnson D, Milhorn DE. 1999. EPAS1 trans-activation during hypoxia requires p42/p44 MAPK. J Biol Chem 274:33709-33713.
2. Davies SP, Reddy H, Caivano M, Cohen P. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95-105.
3. Folkman J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31.
4. G25/MN by HIF-1α in clear cell renal cell carcinoma. Oncogene 23:5624-5631.
5. Gupta S, Plattner R, Der CJ, Stanbridge EJ. 2000. Dissection of Ras-dependent signaling pathways controlling aggressive tumor growth of human fibrosarcoma cells: Evidence for a potential novel pathway. Mol Cel Biol 20:9294-9306.
6. Huang LE, Bunn HF. 2003. Hypoxia-inducible factor and its biomedical relevance. J Biol Chem 278:19575-19578.
7. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95:7987-7992.
8. Ivanov S, Liao SY, Ivanova A, Danilkovitch-Miagkova A, Tarasova N, Weirich G, Merril MJ, Proescholdt MA, Oldfield EH, Lee J, Závada J, Waheed A, Sly W, Lerman MI, Stanbridge EJ. 2001. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol 158:905-919.
9. Kaluz S, Kaluzová M, Opavský R, Pastoreková S, Gibadulinová A, Dequiedt F, Kettmann R, Pastorek J. 1999. Transcriptional regulation of the MN/CA 9 gene coding for the tumor-associated carbonic anhydrase IX. Identification and characterization of a proximal silencer element. J Biol Chem 274:32588-32595.
10. Kaluz S, Kaluzová M, Chrastina A, Olive PL, Pastoreková S, Pastorek J, Lerman MI, Stanbridge EJ. 2002. Lowered oxygen tension induces expression of the hypoxia marker MN/Carbonic anhydrase IX in the absence of hypoxia-inducible factor 1α stabilization: A role for phosphatidylinositol 3′-kinase. Cancer Res 62:4469-4477.
11. Kaluz S, Kaluzová M, Stanbridge EJ. 2003. Expression of the hypoxia marker carbonic anhydrase IX is critically dependent on SP1 activity. Identification of a novel type of hypoxia-responsive enhancer. Cancer Res 63:917-922.
12. Kaluzová M, Pastoreková S, Švastová E, Pastorek J, Stanbridge EJ, Kaluz S. 2001. Characterization of the MN/CA 9 promoter proximal region-A role for SP and AP1 factors. Biochem J 359:669-677.
13. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML. 2002. Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch. Science 295:858-861.
14. Loncaster JA, Harris AL, Davidson SE, Logue JP, Hunter RD, Wycoff CC, Pastorek J, Ratcliffe PJ, Stratford IJ, West CML. 2001. Carbonic anhydrase (CAK) expression, a potential new intrinsic marker of hypoxia: Correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 61:6394-6399.
15. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, Ahn NG. 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265:966-970.
16. Maxwell P, Dachs GU, Gleadle JM, Nicholls LG, Harris AL, Stratford IJ, Hankinson O, Pugh CW, Ratcliffe PJ. 1997. Hypoxia inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA 94:8104-8109.
17. Maxwell PH, Wiesener M, Chang G-W, Clifford S, Vaux E, Cockman M, Wykoff CC, Pugh C, Maher E, Ratcliffe PJ. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature (Lond) 399:271-275.
18. Milanini J, Viñals F, Pouysségur J, Pagès G. 1998. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts. J Biol Chem 273:18165-18172.
19. Milanini-Mongiat J, Pouysségur J, Pagès G. 2002. Identification of two SP1 phosphorylation sites for p42/p44 mitogen-activated protein kinase. J Biol Chem 277:20631-20639.
20. Olive PL, Aquino-Parsons C, MacPhail SH, Liao SY, Raleigh JA, Lerman MI, Stanbridge EJ. 2001. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res 61:8924-8929.
21. Pastoreková S, Závadová Z, Koštál M, Babušiková J, Závada J. 1992. A novel quasi-viral agent, MaTu, is a two-component system. Virology 187:620-626.
22. Richard DE, Berra E, Gothie E, Roux D, Pouysségur J. 1999. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1α (HIF-1 α) and enhance the transcriptional activity of HIF-1. J Biol Chem 274:32631-32637.
23. Salceda S, Beck I, Srinivas V, Caro J. 1997. Complex role of protein phosphorylation in gene activation by hypoxia. Kidney Int 51:556-559.
24. Sang N, Stiehl DP, Bohensky J, Leshchinsky I, Srinivas V, Caro J. 2003. MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300. J Biol Chem 278:14013-14019.
25. Seger R, Krebs EG. 1995. The MAPK signaling cascade. FASEB J 9:726-735.
26. Semenza GL. 2002. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 64:993-998.
27. Sun H, Charles CH, Lau LF, Tonks NK. 1993. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75:487-493.
28. 2 tension. Proc Natl Acad Sci USA 92:5510-5514.
29. Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL. 2000. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60:7075-7083.
30. Závada J, Závadová Z, Pastoreková S, Čiampor F, Pastorek J, Zelník V. 1993. Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. Int J Cancer 54:268-274.